Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo

NCT04466215 is registered in ClinicalTrials.gov with The Scripps Research Institute as lead sponsor.

NCT NCT04466215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04466215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo
Lead sponsor
The Scripps Research Institute
Phase
Phase 2
Overall status
Completed
Start date
April 15, 2021
Completion date
June 7, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder